Neurocrine Biosciences, Inc. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-24 06:15 am Purchase | 2023-02-23 | 13D | Voyager Therapeutics, Inc. VYGR | NEUROCRINE BIOSCIENCES INC NBIX | 8,575,316 19.900% | 4,395,588 (+105.16%) | Filing |